Home > Insider Trading > Filing (0001209191-23-042305)

Filing Details

Accession Number:: 0001209191-23-042305
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-07-14 18:52:12
Reporting Period:: 2023-07-12

Accepted Time:: 2023-07-14 18:52:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601830	Recursion Pharmaceuticals Inc.	RXRX	Biological Products, (No Disgnostic Substances) (2836)	464099738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1786484	Terry-Ann Burrell	C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2023-07-12	24,302	$11.25	147,545	No	4	S	Direct
Class A Common Stock	Disposition	2023-07-12	78,071	$12.15	69,474	No	4	S	Direct
Class A Common Stock	Disposition	2023-07-12	3,195	$13.18	66,279	No	4	S	Direct
Class A Common Stock	Disposition	2023-07-12	3,157	$14.08	63,122	No	4	S	Direct
Class A Common Stock	Disposition	2023-07-13	8,275	$12.59	54,847	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.